FR2340330A1 - Acides polyvinylbenzenesulfoniques, leur procede de preparation et leur application en tant que medicaments - Google Patents

Acides polyvinylbenzenesulfoniques, leur procede de preparation et leur application en tant que medicaments

Info

Publication number
FR2340330A1
FR2340330A1 FR7703021A FR7703021A FR2340330A1 FR 2340330 A1 FR2340330 A1 FR 2340330A1 FR 7703021 A FR7703021 A FR 7703021A FR 7703021 A FR7703021 A FR 7703021A FR 2340330 A1 FR2340330 A1 FR 2340330A1
Authority
FR
France
Prior art keywords
polyvinylbenzenesulphonic
acids
application
preparation process
medicinal products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7703021A
Other languages
English (en)
French (fr)
Other versions
FR2340330B1 (enrdf_load_stackoverflow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rohm and Haas Co
Original Assignee
Rohm and Haas Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohm and Haas Co filed Critical Rohm and Haas Co
Publication of FR2340330A1 publication Critical patent/FR2340330A1/fr
Application granted granted Critical
Publication of FR2340330B1 publication Critical patent/FR2340330B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F12/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
    • C08F12/02—Monomers containing only one unsaturated aliphatic radical
    • C08F12/04—Monomers containing only one unsaturated aliphatic radical containing one ring
    • C08F12/14—Monomers containing only one unsaturated aliphatic radical containing one ring substituted by hetero atoms or groups containing heteroatoms
    • C08F12/30—Sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/44—Preparation of metal salts or ammonium salts
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2800/00—Copolymer characterised by the proportions of the comonomers expressed
    • C08F2800/10—Copolymer characterised by the proportions of the comonomers expressed as molar percentages
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2800/00—Copolymer characterised by the proportions of the comonomers expressed
    • C08F2800/20—Copolymer characterised by the proportions of the comonomers expressed as weight or mass percentages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7703021A 1976-02-04 1977-02-03 Acides polyvinylbenzenesulfoniques, leur procede de preparation et leur application en tant que medicaments Granted FR2340330A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65520076A 1976-02-04 1976-02-04
US75269376A 1976-12-20 1976-12-20

Publications (2)

Publication Number Publication Date
FR2340330A1 true FR2340330A1 (fr) 1977-09-02
FR2340330B1 FR2340330B1 (enrdf_load_stackoverflow) 1981-05-29

Family

ID=27096927

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7703021A Granted FR2340330A1 (fr) 1976-02-04 1977-02-03 Acides polyvinylbenzenesulfoniques, leur procede de preparation et leur application en tant que medicaments

Country Status (10)

Country Link
JP (1) JPS5296748A (enrdf_load_stackoverflow)
AU (1) AU514389B2 (enrdf_load_stackoverflow)
CA (1) CA1114997A (enrdf_load_stackoverflow)
DE (1) DE2704329A1 (enrdf_load_stackoverflow)
DK (1) DK44777A (enrdf_load_stackoverflow)
FR (1) FR2340330A1 (enrdf_load_stackoverflow)
GB (1) GB1576016A (enrdf_load_stackoverflow)
IE (1) IE44690B1 (enrdf_load_stackoverflow)
NL (1) NL7701168A (enrdf_load_stackoverflow)
SE (2) SE430070B (enrdf_load_stackoverflow)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068453A3 (en) * 1981-06-29 1983-06-15 Adria Laboratories, Inc. Compositions for treating kidney stones
EP0099477A3 (en) * 1982-06-25 1984-07-25 National Starch And Chemical Corporation Contraceptive composition
EP0579153A3 (en) * 1992-07-13 1994-05-18 Tosoh Corp Process for producing tertiary alcohol, and for preparing catalyst therefor

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375461A (en) * 1980-07-25 1983-03-01 Johnson & Johnson Products, Inc. Sulfonated vinyl aromatic homopolymers and copolymers as dental plaque barriers
US6290946B1 (en) 1999-05-13 2001-09-18 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders and antibacterial agents
EP1800686A3 (en) * 1999-05-13 2009-12-30 Genzyme Corporation Anionic polymers as toxin binders and antibacterial agents
US6270755B1 (en) 1999-05-13 2001-08-07 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders
CA2314494A1 (en) 2000-05-02 2001-11-02 Geltex Pharmaceuticals, Inc. Anionic polymers as species specific antibacterial agents
EP1508578A4 (en) * 2002-05-24 2006-01-04 Sony Corp ION-CONDUCTIVE POLYMER, SOLID POLYELECTROLYT AND CELL THEREOF TO WHICH IT APPLIES
CN101319023A (zh) * 2002-07-22 2008-12-10 基酶有限公司 聚(钾和钠的苯乙烯苯磺酸盐),其制备及其用途
AU2003903547A0 (en) * 2003-07-10 2003-07-24 Neoferma Australia Pty Ltd Structures and methods of waterproofing same
JP6271378B2 (ja) * 2014-09-05 2018-01-31 信越化学工業株式会社 導電性ポリマー用高分子化合物及びその製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3310481A (en) * 1962-09-10 1967-03-21 Dow Chemical Co Removal of residual monomeric sulfonates from polymerizates thereof
JPS4936644A (enrdf_load_stackoverflow) * 1972-08-15 1974-04-05

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068453A3 (en) * 1981-06-29 1983-06-15 Adria Laboratories, Inc. Compositions for treating kidney stones
EP0099477A3 (en) * 1982-06-25 1984-07-25 National Starch And Chemical Corporation Contraceptive composition
EP0579153A3 (en) * 1992-07-13 1994-05-18 Tosoh Corp Process for producing tertiary alcohol, and for preparing catalyst therefor
US5672782A (en) * 1992-07-13 1997-09-30 Tosoh Corporation Process for producing tertiary alcohol and for preparing catalyst therefor

Also Published As

Publication number Publication date
JPS5296748A (en) 1977-08-13
AU514389B2 (en) 1981-02-05
IE44690B1 (en) 1982-02-24
SE426835B (sv) 1983-02-14
DE2704329A1 (de) 1977-08-18
SE430070B (sv) 1983-10-17
NL7701168A (nl) 1977-08-08
IE44690L (en) 1977-08-04
AU2193477A (en) 1978-08-10
CA1114997A (en) 1981-12-22
SE7700670L (sv) 1977-08-05
SE8106138L (sv) 1981-10-16
FR2340330B1 (enrdf_load_stackoverflow) 1981-05-29
DK44777A (da) 1977-08-05
GB1576016A (en) 1980-10-01

Similar Documents

Publication Publication Date Title
FR2337718A1 (fr) Nouveaux hydroxy-benzodiheterocycles etherifies, leur procede de preparation et leur application en tant que medicaments
BE864834A (fr) Nouvelles 4-acylamino-phenyl-ethanolamines, procede pour leur preparation et leur utilisation en tant que medicaments
BE854843A (fr) Nouveaux derives d'acides phosphoneux, leur preparation et leur application en tant que medicaments
BE848310A (fr) Acides di(phenoxy-2 alcane carboxyliques), leur procede de preparation et leur utilisation comme medicaments
FR2282893A1 (fr) Derives de thienothiazine utiles en tant que medicaments et leur procede de preparation
FR2340330A1 (fr) Acides polyvinylbenzenesulfoniques, leur procede de preparation et leur application en tant que medicaments
FR2351996A1 (fr) Composes 9-(3,5-di-o-acyl-b-d-arabinofuranosyl)-adeniniques, leur procede de preparation et leur application en tant que medicaments
BE845581A (fr) Nouvelles oxazolidinones-(2), leur procede de preparation et leur application en tant que medicaments
FR2285864A1 (fr) Nouveaux derives polyeniques, leur procede de preparation et leur application en tant que medicaments
FR2351993A1 (fr) Composes 9-(3-o-acyl-b-d-arabinofuranosyl)adeniniques, composes 9-(2,3-di-o-acyl-b-d-arabinofuranosyl)-adeniniques, leur procede de preparation, et leur application en tant que medicaments
MC1223A1 (fr) Nouveaux derives de 2-imino-imidazolidine,leur preparation et leur application en tant que medicaments
FR2351995A1 (fr) Composes 9-(2-o-acyl-b-d-arabinofuranosyl)-adeniniques, leur procede de preparation et leur application en tant que medicaments
BE869275A (fr) Nouveaux derives d'esters de vincaminol, leur preparation et leur application en tant que medicaments
BE869640A (fr) Nouveaux acides 2-pyridyl- et 2-pyrimidyl-amino-benzoiques, leur preparation et leur utilisation en tant que medicaments
FR2294708A1 (fr) Nouvelles 3-fluoro-2,3-dihydro-1h-1,4-benzodiazepine-2-ones, utiles en tant que medicaments et leur procede de preparation
FR2285870A1 (fr) Nouveaux derives de benzofurane, leur procede de preparation et leur application en tant que medicaments
FR2321293A1 (fr) Nouveaux acides 7b-(d-2-amino-2-(alcoyl inferieur-sulfonylamino-phenyl)- acetylamino)-3-r-3-cephem-4-carboxyliques, leur procede de preparation et leur application en tant que medicaments
BE862275A (fr) Nouveaux acides sulfamoylbenzoiques, leur preparatrion et leur application en tant que medicaments
FR2341584A1 (fr) Nouveaux derives de thienothiazine, leur procede de preparation et leur application en tant que medicaments
FR2351994A1 (fr) Composes 9-(5-o-acyl-b-d-arabinofuranosyl)-adeniniques, procede pour leur preparation et application en tant que medicaments
FR2315260A1 (fr) Nouveaux composes araliphatiques dihalogenes, leur application en tant que medicaments et leur procede de preparation
FR2292472A1 (fr) Nouveaux derives d'isoindole utiles en tant que medicaments, et leur procede de preparation
FR2344286A1 (fr) Nouveaux derives 17-spirosultines, les g-hydroxy acides correspondants, leur procede de preparation et leur application comme medicament
MC1222A1 (fr) Nouvelles 2,4-diamino-5-benzylpyrimidines,leur preparation et leur application en tant que medicaments
FR2318644A1 (fr) Nouveaux fluoteroides, leur application en tant que medicaments et leur procede de preparation

Legal Events

Date Code Title Description
ST Notification of lapse